Childhood cancer Survivors' sleep under the microscope
NCT ID NCT05480904
First seen Jun 27, 2026 · Last updated Aug 20, 2026 · Updated 2 times
Summary
This study looks at sleep problems in adults who had childhood cancer. About 200 survivors of leukemia, brain tumors, or solid tumors will wear sleep monitors and answer questionnaires. The goal is to find out how common sleep disorders are and how they relate to other health issues.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how common sleep problems are in childhood cancer survivors and point to ways to improve their long-term health.
- What could go wrong
- This is an observational study, not a treatment trial. It may find associations but cannot prove cause and effect, and results may not apply to all survivors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 199 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2023
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
All participants who meet eligibility criteria and consent to enrollment on the study.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participant in SJLIFE and \> 5 years from diagnosis. * \>18 years of age at time of enrollment. * Diagnosed with ALL (treated with CRT or chemotherapy only) or CNS tumors (posterior fossa tumors or supratentorial tumors) or non-CNS solid tumors (with abdominal or chest radiation or bilateral retinoblastoma survivors). * Participant was less than 21 years of age at time of diagnosis. * Speaks and understands English (polysomnography device speaks to patients only in English). * Remote participant must have Wi-Fi access Exclusion Criteria: * Estimated intelligence score \<80. * Currently prescribed an intervention for a sleep disorder. * Survivor of craniopharyngioma. * Survivor of Hodgkin Lymphoma. * Relapsed or treated with hematopoietic stem cell therapy. * Brain injury unrelated to cancer diagnosis or therapy. * Pulmonary injury unrelated to cancer diagnosis or therapy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALL, adult are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an experimental pill boost cancer immunotherapy? early trial puts HG146 to the test
- New injectable drug tested for safety in Hard-to-Treat solid tumors
- First human test of BI 4060107 aims to find safe dose for Hard-to-Treat tumors
- Can a new drug shield kidneys from chemotherapy damage?
- Mining Responders' tumors for clues to a universal cancer therapy
- Proton boost radiotherapy aims to hit large tumors harder while sparing healthy tissue